Literature DB >> 21180565

Challenges in developing new multiple sclerosis therapies.

Michael K Racke1.   

Abstract

Year:  2008        PMID： 21180565      PMCID： PMC3002543          DOI： 10.1177/1756285608095831

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN： 1756-2856            Impact factor:   6.570


× No keyword cloud information.
  7 in total

Review 1.  Multiple sclerosis--the plaque and its pathogenesis.

Authors:  Elliot M Frohman; Michael K Racke; Cedric S Raine
Journal:  N Engl J Med       Date:  2006-03-02       Impact factor: 91.245

2.  Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group.

Authors:  R A Rudick; E Fisher; J C Lee; J Simon; L Jacobs
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

Review 3.  Reactivation of JC virus and development of PML in patients with multiple sclerosis.

Authors:  K Khalili; M K White; F Lublin; P Ferrante; J R Berger
Journal:  Neurology       Date:  2007-03-27       Impact factor: 9.910

4.  B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.

Authors:  Stephen L Hauser; Emmanuelle Waubant; Douglas L Arnold; Timothy Vollmer; Jack Antel; Robert J Fox; Amit Bar-Or; Michael Panzara; Neena Sarkar; Sunil Agarwal; Annette Langer-Gould; Craig H Smith
Journal:  N Engl J Med       Date:  2008-02-14       Impact factor: 91.245

5.  Serial whole-brain magnetization transfer imaging in patients with relapsing-remitting multiple sclerosis at baseline and during treatment with interferon beta-1b.

Authors:  N D Richert; J L Ostuni; C N Bash; J H Duyn; H F McFarland; J A Frank
Journal:  AJNR Am J Neuroradiol       Date:  1998-10       Impact factor: 3.825

Review 6.  Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis.

Authors:  R Zivadinov; A T Reder; M Filippi; A Minagar; O Stüve; H Lassmann; M K Racke; M G Dwyer; E M Frohman; O Khan
Journal:  Neurology       Date:  2008-07-08       Impact factor: 9.910

Review 7.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria".

Authors:  Chris H Polman; Stephen C Reingold; Gilles Edan; Massimo Filippi; Hans-Peter Hartung; Ludwig Kappos; Fred D Lublin; Luanne M Metz; Henry F McFarland; Paul W O'Connor; Magnhild Sandberg-Wollheim; Alan J Thompson; Brian G Weinshenker; Jerry S Wolinsky
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422
  7 in total
  2 in total

1.  Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis.

Authors:  Arief Rahman Afief; Lalu Muhammad Irham; Wirawan Adikusuma; Dyah Aryani Perwitasari; Ageng Brahmadhi; Rocky Cheung
Journal:  Biochem Biophys Rep       Date:  2022-09-05

Review 2.  In Situ-Based Gels for Nose to Brain Delivery for the Treatment of Neurological Diseases.

Authors:  Blessing Atim Aderibigbe
Journal:  Pharmaceutics       Date:  2018-03-30       Impact factor: 6.321
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.